Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 1 · 100%Moderate 0 · 0%High 0 · 0%

Mid‐dose mifepristone (25 mg‐50 mg) vs levonorgestrel 1.5 mg

Specific side effects ‐ spotting/bleeding after treatment · women seeking emergency contraception

Mid‐dose mifepristone (25 mg‐50 mg) may leads to lower specific side effect ‐ spotting/bleeding after treatment compared with levonorgestrel 1.5 mg (low certainty).

1 finding from 1 review

Interventions for emergency contraception 2019 · Cochrane Headline outcomes only
RR 0.61 [0.42, 0.88]
9 studies · 1796 participants
Low